ImmunityBio, Inc. announced on December 23, 2025, a major agreement allowing the sale of up to $459,972,480 worth of additional common stock. This amendment updates their existing market offering with Jefferies LLC and follows a prior increase in authorized shares from 1.35 billion to 1.65 billion.